Abid M Ruhul, Sellke Frank W
Cardiovascular Research Center, Department of Surgery, Rhode Island Hospital, Brown University Warren Alpert Medical School, Providence, RI, USA.
Pharm Anal Acta. 2015 Jan;6(1). doi: 10.4172/2153-2435.1000323.
General use and popularity of over-the-counter supplemental antioxidants have rapidly spread all over the world and are believed to promote cardiovascular health and wellbeing. However, there is a paucity of information and lack of proof that physiological and above-physiological levels of oxidants do harm at the cellular and organismal levels. Instead, several reports demonstrated that reduction in Reactive Oxygen Species (ROS) did not improve vascular function. Interestingly, recent studies show that increased ROS levels play protective role in vascular endothelium and may improve coronary endothelial function. In the current review, we introduce the concept that increased ROS levels, often seen in association with cardiovascular disease, probably is an endothelial-way or 'oxidative response' to cope with vascular pathology.
非处方补充抗氧化剂的广泛使用和普及已迅速在全球传播,并被认为可促进心血管健康。然而,关于氧化剂在生理和超生理水平上对细胞和机体层面造成损害的信息匮乏且缺乏证据。相反,一些报告表明,活性氧(ROS)水平的降低并未改善血管功能。有趣的是,最近的研究表明,ROS水平升高在血管内皮中起保护作用,并可能改善冠状动脉内皮功能。在本综述中,我们提出这样一个概念,即在心血管疾病中常见的ROS水平升高,可能是一种内皮应对血管病变的方式或“氧化反应”。